# KYMR (Kymera Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Kymera Therapeutics, Inc. reported $102.2M in revenue and a net loss of $349.4M for the trailing twelve months ended September 30, 2026 (down 100.0% year over year), with a 0.0% gross margin and a -396.0% operating margin.

- Canonical: https://convexityos.com/fundamentals/KYMR
- Markdown: https://convexityos.com/fundamentals/KYMR.md
- SEC CIK: 0001815442
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:09 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001815442&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $102.2M | -100.0% YoY |
| Operating Income | TTM | -$404.9M | -396.0% margin |
| Net Income | TTM | -$349.4M | -341.8% net margin |
| Diluted EPS | TTM | -$3.49 | Split-adjusted |
| Free Cash Flow | TTM | -$288.9M | -282.6% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $971.2M | Total debt: $76.60M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $39.21M | $47.07M | $78.59M | $46.83M | $72.83M | $34.03M | $2.93M |
| Cost of Revenue | $39.21M | $47.07M | $78.59M | $46.83M | -- | -- | -- |
| **Gross Profit** | $0 | $0 | $0 | $0 | -- | -- | -- |
| Research & Development | $316.6M | $240.2M | $189.1M | $164.2M | $137.0M | $62.10M | $37.16M |
| Total Operating Expenses | $388.6M | $308.7M | $244.1M | $208.1M | $173.4M | $80.34M | $45.14M |
| **Operating Income** | -$349.4M | -$261.6M | -$165.5M | -$161.3M | -$100.5M | -$46.30M | -$42.20M |
| **EBITDA** | -$341.1M | -$254.3M | -$162.0M | -$158.3M | -$98.13M | -$44.54M | -$41.38M |
| Interest Income | $38.42M | $38.03M | $18.76M | $6.62M | -- | -- | -- |
| Income Before Tax | -$311.4M | -- | -- | -- | -- | -- | -- |
| Income Tax Expense | $0 | -- | -- | $0 | $0 | $0 | $0 |
| **Net Income** | -$311.4M | -$223.9M | -$147.0M | -$154.8M | -$100.2M | -$45.59M | -$41.25M |
| Basic EPS | -$3.69 | -$2.98 | -$2.52 | -$2.87 | -$2.09 | -$3.15 | -$24.28 |
| **Diluted EPS** | -$3.69 | -$2.98 | -$2.52 | -$2.87 | -$2.09 | -$3.15 | -$24.28 |
| Basic Shares Outstanding | 84.5M | 75.0M | 58.4M | 53.9M | 48.0M | 17.3M | 1.7M |
| Diluted Shares Outstanding | 84.5M | 75.0M | 58.4M | 53.9M | 48.0M | 17.3M | 1.7M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $65.00M | $34.37M | $2.87M | $2.76M | $11.48M | $22.10M | $7.39M |
| Cost of Revenue | $0 | $65.00M | $34.37M | $2.87M | $2.76M | $11.48M | $22.10M | $7.39M |
| **Gross Profit** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Research & Development | $128.5M | $119.5M | $98.16M | $83.83M | $74.09M | $78.39M | $80.25M | $71.82M |
| Total Operating Expenses | $147.2M | $140.6M | $118.5M | $100.8M | $95.28M | $96.03M | $96.53M | $88.15M |
| **Operating Income** | -$147.2M | -$75.61M | -$84.15M | -$97.90M | -$92.52M | -$84.56M | -$74.43M | -$80.75M |
| **EBITDA** | -$145.2M | -$73.58M | -$82.13M | -$95.86M | -$90.37M | -$82.47M | -$72.38M | -$78.77M |
| Interest Income | $15.29M | $14.48M | $14.98M | $11.01M | $10.44M | $8.05M | $8.92M | $10.06M |
| **Net Income** | -$132.0M | -$61.21M | -$69.23M | -$86.98M | -$82.17M | -$76.61M | -$65.58M | -$70.75M |
| Basic EPS | -$1.32 | -$0.62 | -$0.71 | -- | -$0.94 | -$0.95 | -$0.82 | -- |
| **Diluted EPS** | -$1.32 | -$0.62 | -$0.71 | -- | -$0.94 | -$0.95 | -$0.82 | -- |
| Basic Shares Outstanding | 100.1M | 98.2M | 97.5M | -- | 87.3M | 80.4M | 80.1M | -- |
| Diluted Shares Outstanding | 100.1M | 98.2M | 97.5M | -- | 87.3M | 80.4M | 80.1M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $357.0M | $120.3M | $110.0M | $68.39M | $47.98M | $31.00M | $76.02M |
| Short-Term Investments | $491.3M | $368.5M | $264.9M | $338.8M | $394.4M | $265.2M | $15.94M |
| **Cash & Short-Term Investments** | $848.3M | $488.7M | $374.9M | $407.2M | $442.4M | $296.2M | $91.96M |
| Accounts Receivable, Net | $0 | $0 | $15.00M | $0 | -- | -- | -- |
| **Total Current Assets** | $871.2M | $510.3M | $405.3M | $419.4M | $451.3M | $302.3M | $92.84M |
| Property, Plant & Equipment, Net | $43.17M | $50.46M | $48.13M | $13.33M | $11.88M | $10.84M | $3.79M |
| Long-Term Investments | $771.2M | $362.2M | $61.43M | $152.3M | $125.2M | $162.5M | -- |
| Other Non-Current Assets | $9.11M | $1.95M | $2.12M | $3.02M | $2.02M | $30K | $1.77M |
| **Total Non-Current Assets** | $871.6M | $467.8M | $170.4M | $183.7M | $154.6M | $184.8M | $23.86M |
| **Total Assets** | $1.74B | $978.0M | $575.8M | $603.1M | $605.9M | $487.2M | $116.7M |
| Accounts Payable | $4.01M | $5.99M | $7.08M | $4.33M | $4.00M | $4.37M | $3.28M |
| Deferred Revenue (Current) | $22.93M | $13.58M | $37.88M | $35.26M | $61.74M | $92.55M | $23.35M |
| Other Current Liabilities | $242K | $223K | $524K | $303K | $228K | $106K | -- |
| **Total Current Liabilities** | $83.21M | $67.77M | $85.69M | $71.34M | $92.54M | $110.6M | $34.57M |
| Deferred Revenue (Non-Current) | $11.44M | $0 | $16.77M | $28.00M | $39.30M | $77.84M | $29.64M |
| Other Non-Current Liabilities | -- | $0 | $0 | $248K | $66K | $100K | -- |
| **Total Non-Current Liabilities** | $79.94M | $74.65M | $95.10M | $41.64M | $53.73M | $92.67M | $47.46M |
| **Total Liabilities** | $163.1M | $142.4M | $180.8M | $113.0M | $146.3M | $203.3M | $82.03M |
| **Total Debt (incl. Leases)** | $82.25M | $87.76M | $84.67M | $17.34M | $17.96M | $17.99M | $21.19M |
| Common Stock | $8.0K | $7.0K | $6.0K | $6.0K | $5.0K | $4.0K | -- |
| Retained Earnings | -$1.07B | -$754.6M | -$530.8M | -$383.8M | -$229.0M | -$128.8M | -$76.46M |
| Accumulated Other Comp. Income | $1.80M | -$1.49M | -$552K | -$4.95M | -$660K | -$128K | $6.0K |
| **Total Stockholders' Equity** | $1.58B | $835.6M | $395.0M | $490.2M | $459.6M | $283.9M | -$74.41M |
| Total Equity | $1.58B | $835.6M | $395.0M | $490.2M | $459.6M | $283.9M | -$74.41M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $373.4M | $124.5M | $144.1M | $357.0M | $112.9M | $335.8M | $89.97M | $120.3M |
| Short-Term Investments | $597.8M | $566.5M | $506.8M | $491.3M | $392.7M | $329.6M | $373.2M | $368.5M |
| **Cash & Short-Term Investments** | $971.2M | $691.0M | $650.9M | $848.3M | $505.7M | $665.4M | $463.1M | $488.7M |
| Accounts Receivable, Net | -- | $20.00M | -- | $0 | -- | $40.00M | -- | $0 |
| **Total Current Assets** | $998.6M | $737.3M | $677.4M | $871.2M | $528.3M | $728.3M | $501.0M | $510.3M |
| Property, Plant & Equipment, Net | $38.24M | $39.97M | $41.62M | $43.17M | $45.13M | $48.57M | $49.17M | $50.46M |
| Long-Term Investments | $674.7M | $813.9M | $894.7M | $771.2M | $473.1M | $297.6M | $312.3M | $362.2M |
| Other Non-Current Assets | $9.11M | $7.38M | $7.70M | $9.11M | $6.83M | $4.67M | $3.31M | $1.95M |
| **Total Non-Current Assets** | $768.7M | $908.2M | $991.6M | $871.6M | $573.7M | $402.7M | $417.4M | $467.8M |
| **Total Assets** | $1.77B | $1.65B | $1.67B | $1.74B | $1.10B | $1.13B | $918.3M | $978.0M |
| Accounts Payable | $11.92M | $8.92M | $12.84M | $4.01M | $5.51M | $5.78M | $10.26M | $5.99M |
| Deferred Revenue (Current) | $0 | $0 | $0 | $22.93M | $23.28M | $40.00M | $11.48M | $13.58M |
| Other Current Liabilities | $905K | $236K | $976K | $242K | $408K | $117K | $893K | $223K |
| **Total Current Liabilities** | $89.72M | $71.33M | $62.64M | $83.21M | $71.58M | $87.54M | $58.99M | $67.77M |
| Deferred Revenue (Non-Current) | $0 | $0 | $0 | $11.44M | $13.96M | -- | -- | $0 |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Non-Current Liabilities** | $63.02M | $64.86M | $66.74M | $79.94M | $84.21M | $72.05M | $73.09M | $74.65M |
| **Total Liabilities** | $152.7M | $136.2M | $129.4M | $163.1M | $155.8M | $159.6M | $132.1M | $142.4M |
| **Total Debt (incl. Leases)** | $76.60M | $78.56M | $80.47M | $82.25M | $84.00M | $85.71M | $86.33M | $87.76M |
| Common Stock | $9.0K | $8.0K | $8.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K |
| Retained Earnings | -$1.33B | -$1.20B | -$1.14B | -$1.07B | -$979.0M | -$896.8M | -$820.2M | -$754.6M |
| Accumulated Other Comp. Income | -$14.73M | -$7.16M | -$4.19M | $1.80M | $1.50M | $279K | -$58K | -$1.49M |
| **Total Stockholders' Equity** | $1.61B | $1.51B | $1.54B | $1.58B | $946.3M | $971.5M | $786.2M | $835.6M |
| Total Equity | $1.61B | $1.51B | $1.54B | $1.58B | $946.3M | $971.5M | $786.2M | $835.6M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$311.4M | -$223.9M | -$147.0M | -$154.8M | -$100.2M | -$45.59M | -$41.25M |
| Depreciation & Amortization | $8.31M | $7.37M | $3.56M | $2.98M | $2.40M | $1.76M | $825K |
| Stock-Based Compensation | $59.90M | $55.01M | $43.12M | $35.48M | $24.97M | $5.19M | $1.20M |
| Change in Payables | -$1.97M | -$307K | $2.04M | $253K | $54K | $990K | $904K |
| **Operating Cash Flow** | -$232.9M | -$194.5M | -$102.8M | -$153.1M | -$128.9M | $88.13M | $17.91M |
| Capital Expenditure | -$1.45M | -$12.84M | -$34.48M | -$2.84M | -$1.60M | -$9.10M | -$532K |
| **Free Cash Flow** | -$234.3M | -$207.3M | -$137.3M | -$155.9M | -$130.5M | $79.03M | $17.37M |
| Purchases of Investments | -$1.01B | -$901.2M | -$189.2M | -$446.0M | -$456.4M | -$529.4M | -$15.95M |
| **Investing Cash Flow** | -$521.1M | -$404.1M | $139.9M | $20.52M | -$99.83M | -$422.6M | -$16.49M |
| **Financing Cash Flow** | $990.7M | $608.9M | $4.19M | $153.0M | $250.3M | $289.3M | $34.91M |
| **Net Change in Cash** | $236.8M | $10.27M | $41.25M | $20.43M | $21.50M | -$45.20M | $36.33M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$132.0M | -$61.21M | -$69.23M | -$86.98M | -$82.17M | -$76.61M | -$65.58M | -$70.75M |
| Depreciation & Amortization | $2.02M | $2.03M | $2.02M | $2.03M | $2.15M | $2.08M | $2.05M | $1.99M |
| Stock-Based Compensation | $18.84M | $18.94M | $16.01M | $14.45M | $15.80M | $15.42M | $14.23M | $13.80M |
| Change in Payables | $3.02M | -$3.94M | $8.82M | -$1.49M | -$267K | -$4.13M | $3.92M | -$505K |
| **Operating Cash Flow** | -$77.91M | -$54.06M | -$88.84M | -$66.75M | -$27.11M | -$59.88M | -$79.15M | -$61.78M |
| Capital Expenditure | -$315K | -$473K | -$434K | -$106K | -$181K | -$695K | -$467K | -$936K |
| **Free Cash Flow** | -$78.23M | -$54.54M | -$89.27M | -$66.85M | -$27.29M | -$60.58M | -$79.62M | -$62.72M |
| Purchases of Investments | -$60.66M | -$114.7M | -$276.3M | -- | -$367.6M | -$58.25M | -$83.66M | -- |
| Sales & Maturities of Investments | $162.6M | $135.2M | $133.9M | -- | $132.4M | $119.0M | $132.7M | -- |
| **Investing Cash Flow** | $101.6M | $20.05M | -$142.8M | -$394.4M | -$235.3M | $60.02M | $48.62M | $68.57M |
| **Financing Cash Flow** | $225.6M | $14.42M | $18.77M | $705.2M | $39.51M | $245.7M | $258K | $2.77M |
| **Net Change in Cash** | $249.3M | -$19.60M | -$212.9M | $244.1M | -$222.9M | $245.9M | -$30.28M | $9.55M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 0.0% | 0.0% | 0.0% | 0.0% | -- | -- | -- |
| **Operating Margin** | -891.1% | -555.8% | -210.6% | -344.4% | -138.0% | -136.1% | -1438.5% |
| **Net Profit Margin** | -794.0% | -475.6% | -187.0% | -330.6% | -137.6% | -134.0% | -1405.8% |
| Return on Equity (ROE) | -19.7% | -26.8% | -37.2% | -31.6% | -21.8% | -16.1% | -- |
| Return on Assets (ROA) | -17.9% | -22.9% | -25.5% | -25.7% | -16.5% | -9.4% | -35.3% |
| Current Ratio | 10.47x | 7.53x | 4.73x | 5.88x | 4.88x | 2.73x | 2.69x |
| Quick Ratio | 10.19x | 7.21x | 4.55x | 5.71x | 4.78x | 2.68x | 2.66x |
| Debt to Equity | 0.05x | 0.11x | 0.21x | 0.04x | 0.04x | 0.06x | -- |
| **Revenue Growth (YoY)** | -16.7% | -40.1% | +67.8% | -35.7% | +114.0% | +1060.0% | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -246.3% | +392.2% | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -265.2% | +354.9% | -- |
| 5Y Revenue / Share Growth | -76.3% | -63.7% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| **Operating Margin** | -396.0% | -333.5% | -697.7% | -891.1% | -759.7% | -697.5% | -472.5% | -555.8% |
| **Net Profit Margin** | -341.8% | -285.3% | -612.0% | -794.1% | -674.8% | -616.0% | -409.1% | -475.6% |
| Return on Equity (ROE) | -21.6% | -19.9% | -20.5% | -19.7% | -31.2% | -28.4% | -30.6% | -26.8% |
| Return on Assets (ROA) | -19.8% | -18.2% | -18.9% | -17.9% | -26.8% | -24.4% | -26.2% | -22.9% |
| Current Ratio | 11.13x | 10.34x | 10.81x | 10.47x | 7.38x | 8.32x | 8.49x | 7.53x |
| Quick Ratio | 10.82x | 9.97x | 10.39x | 10.19x | 7.07x | 8.06x | 7.85x | 7.21x |
| Debt to Equity | 0.05x | 0.05x | 0.05x | 0.05x | 0.09x | 0.09x | 0.11x | 0.11x |
| **Revenue Growth (YoY)** | -100.0% | +466.4% | +55.5% | -61.2% | -26.1% | -55.3% | +114.8% | -84.6% |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -868.0% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
